House dust mites induce proliferation of severe asthmatic smooth muscle cells via an epithelium-dependent pathway

Thomas Trian1, Benoit Allard, Isabelle Dupin

  • 11 Département de Pharmacologie and.

Abstract

Insights

House dust mites (HDM) selectively increase bronchial smooth muscle (BSM) proliferation in severe asthma by stimulating the airway epithelium. This pathway involves leukotriene production and receptor expression, suggesting new therapeutic targets for severe asthma.

Area of Science:

  • * Respiratory Medicine
  • * Immunology
  • * Cell Biology

Background:

  • * Asthma control is linked to indoor allergen sensitization, particularly house dust mites (HDM).
  • * Severe asthma is associated with bronchial remodeling, including increased bronchial smooth muscle (BSM) mass.
  • * The link between HDM-induced epithelial changes and BSM remodeling remains unclear.

Purpose of the Study:

  • * To investigate if HDM stimulation of the airway epithelium triggers BSM cell proliferation in severe asthma patients.
  • * To elucidate the underlying molecular mechanisms involved in this interaction.

Main Methods:

  • * An in vitro air-liquid interface (ALI) culture model combining epithelium and BSM was used.
  • * Bronchial smooth muscle (BSM) proliferation was measured via BrdU incorporation.
  • * Epithelial mediators, leukotriene production, and receptor expression (CysLTR1) were analyzed using RT-PCR, ELISA, and flow cytometry.

Main Results:

  • * HDM stimulation selectively enhanced BSM proliferation in severe asthma patients, not in non-asthmatic controls.
  • * This effect was mediated by epithelial protease-activated receptor-2 (PAR-2) signaling, leading to leukotriene C4 production.
  • * Asthmatic BSM cells showed overexpression of the leukotriene receptor CysLTR1.

Conclusions:

  • * HDM plays a selective role in BSM remodeling in severe asthma.
  • * The findings highlight a critical epithelial-BSM crosstalk pathway.
  • * This research identifies potential therapeutic targets at both epithelial and smooth muscle levels for severe asthma management.

Related Concept Videos

Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
5.0K
Asthma I: Introduction01:28

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
3
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.7K
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.8K
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
2
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
5.3K